Weekly Mass Torts Bulletin 2022-May-23

The drug manufacturer Mallinckrodt which has been announced to be bankrupt will have to pay an $18 million settlement to Washington over its role in fueling the opioid crisis in the state.

Weekly Mass Torts Bulletin 2022-May-16

A trial has begun in federal court in Cleveland, where a judge will decide the amount of penalty the two Ohio counties will get from CVS, Walgreens and Walmart pharmacies over the companies' alleged role in the opioid crisis.

Weekly Mass Torts Bulletin 2022-May-09

The state of Florida has reached a $683 million settlement with the Walgreens pharmacy over a lawsuit that accuses the company of improper distribution of opioid painkillers that resulted in the opioid crisis.

Weekly Mass Torts Bulletin 2022-May-02

The U.S. Department of Justice has subpoenaed Royal Philips NV over the recall of defective CPAP sleep apnea machines and respirators, which are alleged of causing severe problems to the users.

Weekly Mass Torts Bulletin 2022-Apr-25

A $10 million settlement which would be paid over the course of 10 years has been reached between Endo Pharmaceuticals and San Francisco over the company's role in the opioid crisis.

Weekly Mass Torts Bulletin 2022-Apr-18

Juul Labs has agreed to pay $22.5 million to Washington state over its e-cigarette as the company is alleged to illicit marketing and sales of the vaping products to the minors.

Weekly Mass Torts Bulletin 2022-Apr-11

Florida lawsuit's settlement of $870 million is accepted by the defendants to get rid of the opioid lawsuits, but Walgreens Co. is still reluctant to accept the agreement.

Weekly Mass Torts Bulletin 2022-Apr-04

A $ 55 million settlement has been rewarded to the Hamilton County area from the national opioid settlement, whereas Northern Kentucky counties might receive $20 million.

Weekly Mass Torts Bulletin 2022-Mar-28

Johnson & Johnson's (J&J) controversial bankruptcy move due to talc litigations will force the settlements for cancer victims, which will eventually result in the rest of the…